SuperworthCoya Therapeutics market cap COYA
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $92.4M
- Highest close in our data
- $144.3M
- Mar 2024
Coya Therapeutics is worth $92.4M at the close on Oct 23, 2026, at $3.94 a share.
That is down 12% over the last year.
Its highest close in our data was $144.3M in Mar 2024.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $92.4M | $89.6M | $137.5M | −19% |
| 2025 | $114.5M | $86.5M | $136.2M | +16% |
| 2024 | $98.9M | $59.9M | $144.3M | +33% |
| 2023 | $74.3M | $33.6M | $74.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Coya Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| COYACoya Therapeutics | $92.4M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| ATNMActinium Pharmaceuticals | $47.8M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Coya Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.